| abstract |
There is provided a pharmaceutical composition comprising, as an active ingredient, a quinoline or quinazoline derivative of the formula (I), a pharmaceutically acceptable salt, isomer, hydrate and solvate thereof as an active ingredient, which is induced by overexpression of a cytotoxic protein Cancer, inflammation, autoimmune disease, or degenerative nerve disorder. |